← Eichor
Study identifier: NCT06523504 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control

Condition: Myopia  ·  Sponsor: Ruihua Wei

PhasePhase 1/Phase 2
Planned participants410
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersNo

About this study

To evaluate the effectiveness and safety of DIMS, low concentration atropine eye drops,and atropine combined with DIMS in controlling axial length and refraction in children with moderate to high myopia.

This description comes directly from the study's public registry record.

Talk to the study team

Meinan He  ·  +8613672135765  ·  hmn509@tmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Tianjin Medical University Eye HospitalTianjin, Tianjin Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06523504